Power 3 Medical Products Inc (fka PWRM)

[Loonley Tunes]

Something about Stem Tronix Inc.

links:
http://docs.google.com/viewer?a=v&q=cache:BmoVEqqdMwQJ:www.researchandmarkets.com/reports/1096074/global_stem_cell_and_advanced_technologies.pdf+StemTroniX+Inc+number+of+O/S&hl=sl&gl=si&sig=AHIEtbT9KBvc0L4WBJ4s9rUeV9Ibz4yjlA

http://www.researchandmarkets.com/reports/1096074/global_stem_cell_and_advanced_technologies_market

from last link:

The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies. The benefits of stem cell therapy are attracting an increasing number of patients. The product submarket for human and embryo stem cells are expected to drive the growth of the overall market. In addition, intensive R&D efforts and the increasing investments into research on stem cells therapy are soon expected to improve the efficacy of stem cell treatment. However, the high cost of the therapy may affect market growth.

The global stem cell market is estimated to be $88.3 billion by 2014, growing at a CAGR of 14.8 % from 2009 to 2014. The U.S. currently holds a 60% share of the global stem cell market; and forms an especially lucrative market for areas such as bone marrow transplantation through stem cells. This research report will help stakeholders gain a better understanding of product pricing and regulatory framework governing the dynamics of the stem cell market. The key players in the market include Osiris Therapeutics, Stem Tronix Inc., Stemcell Technologies, Genzyme Corp., Cytori, and Geron.